Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1511846rdf:typepubmed:Citationlld:pubmed
pubmed-article:1511846lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:1511846lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:1511846lifeskim:mentionsumls-concept:C1522460lld:lifeskim
pubmed-article:1511846lifeskim:mentionsumls-concept:C0032824lld:lifeskim
pubmed-article:1511846lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1511846lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:1511846lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:1511846lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:1511846lifeskim:mentionsumls-concept:C0167029lld:lifeskim
pubmed-article:1511846pubmed:issue3lld:pubmed
pubmed-article:1511846pubmed:dateCreated1992-9-30lld:pubmed
pubmed-article:1511846pubmed:abstractText1. In rat thoracic aorta, LP-805 (0.1-10 microM) caused the marked reduction of NE-induced maximum response and relaxed the low K+ (less than 35.9 mM)-induced contraction, in a concentration-dependent manner, but failed to relax the high K+ (65.9 mM)-induced contraction. 2. Glibenclamide (0.3-1 microM) caused a parallel shift of concentration-response curve produced by LP-805 for 25.9 mM K(+)-induced contraction and prevented the LP-805-induced reduction in maximum response evoked by NE in a concentration-dependent manner. 3. Glibenclamide (10 microM) prevented the LP-805 (10 microM)-induced decrease in cytosolic Ca2+ levels which was increased by 1 microM NE or 25.9 mM K+. 4. LP-805 (10 microM) increased basal 86Rb efflux, which was completely inhibited by 10 microM glibenclamide. 5. The results suggest that LP-805 causes a vasorelaxation as a consequence of the decrease in cytosolic Ca2+ levels due to the increase in K+ efflux via opening ATP-dependent K+ channels.lld:pubmed
pubmed-article:1511846pubmed:languageenglld:pubmed
pubmed-article:1511846pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:citationSubsetIMlld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1511846pubmed:statusMEDLINElld:pubmed
pubmed-article:1511846pubmed:monthMaylld:pubmed
pubmed-article:1511846pubmed:issn0306-3623lld:pubmed
pubmed-article:1511846pubmed:authorpubmed-author:MorimotoTTlld:pubmed
pubmed-article:1511846pubmed:authorpubmed-author:TakayanagiIIlld:pubmed
pubmed-article:1511846pubmed:authorpubmed-author:NakajimaNNlld:pubmed
pubmed-article:1511846pubmed:authorpubmed-author:YamazakiKKlld:pubmed
pubmed-article:1511846pubmed:authorpubmed-author:TsujitaniMMlld:pubmed
pubmed-article:1511846pubmed:authorpubmed-author:KishiiKKlld:pubmed
pubmed-article:1511846pubmed:issnTypePrintlld:pubmed
pubmed-article:1511846pubmed:volume23lld:pubmed
pubmed-article:1511846pubmed:ownerNLMlld:pubmed
pubmed-article:1511846pubmed:authorsCompleteYlld:pubmed
pubmed-article:1511846pubmed:pagination347-53lld:pubmed
pubmed-article:1511846pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:meshHeadingpubmed-meshheading:1511846-...lld:pubmed
pubmed-article:1511846pubmed:year1992lld:pubmed
pubmed-article:1511846pubmed:articleTitleEffects of LP-805, a novel vasorelaxant agent, a potassium channel opener, on rat thoracic aorta.lld:pubmed
pubmed-article:1511846pubmed:affiliationPOLA Pharmaceutical R&D Laboratory, Yokohama, Japan.lld:pubmed
pubmed-article:1511846pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1511846pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1511846lld:pubmed